BIA Events

The leadership development programme for leaders in the Life Sciences

Join us at 25th Global Summit on Nursing Education and Practice held during October 19-20, 2026 at Los Angeles, USA with a theme to Bridging Education and Practice: Advancing Excellence in Nursing. Participants will be awarded both CE Credits (accredited by the California Board of Registered Nursing) and CPD Credits.

We are honored to invite you to the 24th Global Summit on Nursing Education & Health Care, scheduled to take place on October 19–20, 2026, in the vibrant city of Tokyo, Japan. Theme:“Fostering Excellence in Nursing: Research, Education & Collaborative Practice” Participants will have the opportunity to:s ✔ Discover innovative research and best practices in nursing education and clinical care ✔ Engage in meaningful discussions with global healthcare experts and thought leaders ✔ Share knowledge and experiences that advance patient outcomes and nursing excellence ✔ Build impactful international collaborations to strengthen healthcare systems worldwide ✔ Participate in workshops, keynote sessions and panel discussions led by distinguished speakers Join us in Tokyo—or participate virtually—for two enriching days of learning, networking, and professional growth, dedicated to advancing the nursing profession across borders. For more details, please visit: https://nursingeducation.inovineconferences.com

Focusing on rapid fermentation process development and scale-up

When to Engage with Innovate UK Business Connect Join us to discover how Innovate UK Business Connect can help unlock the potential of your innovation. Whether you're exploring an idea, developing a prototype, finding your first customers or preparing for growth, this webinar will help you understand the opportunities available and identify the right support at the right time.

Join the Industrial Biotechnology Innovation Centre (IBioIC) for an intensive 3-day training course designed to elevate your skills in protein purification using Fast Protein Liquid Chromatography (FPLC) on an ÄKTA system. Whether you're just getting started or looking to deepen your knowledge, this course offers the perfect blend of theory, practical demos, and hands-on experience.

Master the mechanics of modern biotech growth at the Creative Disruption Forum on 20 October, held at ARC Oxford (Garsington Road, OX4 2SU). As capital markets recalibrate, relying on outdated financing routes is no longer viable. This senior-level gathering brings together biotech founders, life sciences executives, venture capitalists, and M&A experts to uncover actionable dealmaking and investment strategies that deliver results in today’s environment. Set within the vibrant innovation ecosystem of ARC Oxford—a premier hub for science and technology pioneers—the forum cuts through the noise with candid, unscripted panel discussions and strategic case studies. Dive into the core issues driving value creation, including: Innovative Capital Models: Structuring non-dilutive funding, co-investments, and strategic corporate partnerships. Smart Valuation & Due Diligence: Aligning founder expectations with investor realities to close deals efficiently. Exit Positioning: Preparing early-to-mid stage ventures for successful M&A or public market listings. Connect with key decision-makers across the Golden Triangle, exchange peer-to-peer insights, and build high-value relationships that drive pipeline execution. Event Details: Date: 20 October Venue: ARC Oxford, Garsington Road, Oxford OX4 2SU Audience: Biotech C-Suite, Life Science Investors, Pharma BD&L Teams, and Advisory Leaders Secure your place today to lead the next era of life sciences investment. Further details and tickets on Eventbrite.

Unlock a Faster, Lower-Risk Path to GMP Cell Banking

In this webinar, Dr Blakney will discuss the development of next-generation saRNA platforms designed to generate prolonged therapeutic effects while requiring substantially lower doses than conventional RNA approaches. She will explore how engineering RNA constructs and optimising nanoparticle delivery systems can enhance RNA expression, improve therapeutic performance, and enable new applications across infectious diseases, cancer, and genetic disorders.

By attending this webinar, you will learn: • Insights into Touchlight’s cell-free DNA platform, including R&D and GMP manufacturing capabilities, and experience in supporting advanced therapy clinical programmes. • How Doggybone DNA (dbDNA™) can increase AAV genome titres, improve full capsid percentages, and reduce impurity packaging. • How Pharmaron’s scalable AAV platform enables seamless progression from early feasibility studies through manufacturing. • The value of leveraging small-scale upstream models to accelerate process development while maintaining scalability. • How collaboration with innovators and technology providers helps drive continuous platform evolution. • A case study highlighting the impact of this collaborative, innovation-driven approach on AAV process development.